Filing Details

Accession Number:
0001437749-24-028990
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-11 17:49:22
Reporting Period:
2024-09-09
Accepted Time:
2024-09-11 17:49:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
768408 Cyanotech Corp CYAN Medicinal Chemicals & Botanical Products (2833) 911206026
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201156 / A Michael Davis Cyanotech Corporation
73-4460 Queen Kaahumanu Hwy #102
Kailua-Kona HI 96740
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Cyanotech Corporation Common Stock Acquisiton 2024-09-09 5,000 $0.84 1,318,773 No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Cyanotech Corporation Common Stock Acquisiton 2024-09-10 5,000 $0.83 1,323,773 No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Cyanotech Corporation Common Stock Acquisiton 2024-09-10 66,667 $0.75 1,390,440 No 4 A Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
No 4 A Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Cyanotech Corporation Common Stock 12,119 Direct
Cyanotech Corporation Common Stock 31,250 Indirect By Spouse
Cyanotech Corporation Common Stock 150,000 Indirect By self as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust
Cyanotech Corporation Common Stock 58,000 Indirect By self as trustee for Nettizanne Johnstone Davis GST Exempt Trust
Cyanotech Corporation Common Stock 58,789 Indirect By self as trustee for Nyracai Johnstone Davis GST Exempt Trust
Footnotes
  1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2024
  2. To reduce the Company's ongoing cash expense, the Nominating and Corporate Governance Committee of the Board of Directors adopted a resolution allowing each director to elect to receive his quarterly director fees in the form of restricted stock in lieu of cash. The Reporting Person elected to receive shares of restricted stock in lieu of cash for the fourth quarter of fiscal 2023, the first quarter of fiscal 2024, the third quarter of fiscal 2024, the fourth quarter of fiscal 2024 and the first quarter of fiscal 2025.